Skip to content

QuidelOrtho Corporation QDEL Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-51.4%
Enterprise value$3.8B-20.1%
P/S0.3×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount.

The official record: QuidelOrtho Corporation’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's valuation allowance, deferred tax asset, increase (decrease), amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's valuation allowance, deferred tax asset, increase (decrease), amount?
QuidelOrtho Corporation (QDEL) reported valuation allowance, deferred tax asset, increase (decrease), amount of $28.25M in Q4 2025.
How has QuidelOrtho Corporation's valuation allowance, deferred tax asset, increase (decrease), amount changed year-over-year?
QuidelOrtho Corporation's valuation allowance, deferred tax asset, increase (decrease), amount increased by 261.0% year-over-year, from $7.83M to $28.25M.
What is the long-term trend for QuidelOrtho Corporation's valuation allowance, deferred tax asset, increase (decrease), amount?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's valuation allowance, deferred tax asset, increase (decrease), amount has grown at a 229.6% compound annual growth rate (CAGR), from $10.4M to $113M.
What does valuation allowance, deferred tax asset, increase (decrease), amount mean?
Represents the net change in the valuation allowance established against deferred tax assets, indicating management's expectation regarding the future realization of these assets. A significant increase suggests reduced confidence in utilizing tax benefits, while a decrease suggests improved profitability outlook.